Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea

Clinical trial NCT02471404 · COMPLETED

Trial details

NCT number

NCT02471404

Sponsor

AstraZeneca

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2015-09-21

Primary completion

2017-03-13

Enrollment

939

View on ClinicalTrials.gov